Standard versus Accelerated Speaking Valve Placement after Percutaneous Tracheostomy: A Randomized Controlled...

Area of Science:

• Critical Care Medicine
• Otolaryngology
• Pulmonology

Background:

• Tracheostomy is common in critically ill patients, often leading to impaired speech and swallowing.
• The optimal timing for speaking valve placement after tracheostomy remains unclear, impacting patient communication and recovery.
• Early intervention with speaking valves may offer significant benefits, but feasibility data is limited.

Purpose of the Study:

• To assess the feasibility of accelerated (within 24 hours) versus standard (after 48 hours) speaking valve placement after percutaneous tracheostomy.
• To evaluate patient recruitment, adherence to timing protocols, and initial safety outcomes.
• To explore preliminary effects on speech, swallowing, and patient tolerance.

Main Methods:

• A randomized controlled trial involving 20 awake patients (Glasgow Coma Scale score ≥9) undergoing percutaneous tracheostomy.
• Patients were assigned to either accelerated or standard timing for speaking valve placement.
• Outcomes included feasibility metrics, safety events, speech intelligibility, swallowing function, and decannulation rates.

Main Results:

• Twenty of 36 eligible patients were randomized, indicating feasibility of recruitment.
• Median speaking valve placement was 22 hours (accelerated) vs. 45.5 hours (standard), achieving separation between groups.
• No safety events (aspiration, hypoxemia) occurred. Accelerated group showed better tolerance and higher decannulation rates (7 vs. 1).

Conclusions:

• Speaking valve placement within 24 hours of percutaneous tracheostomy is feasible and safe.
• The accelerated approach demonstrated improved tolerance and earlier decannulation.
• Further multicenter randomized controlled trials are warranted to confirm safety and clinical benefits for speech and swallow recovery.